Articles

Elsevier,

Revista Colombiana de ReumatologíaVolume 32, Issue 3, July–September 2025, Pages 198-208

The high prevalence of musculoskeletal diseases, particularly rheumatoid arthritis, in the Misak indigenous community—originally from Colombia— is likely influenced by cultural, socioeconomic, genetic, and environmental factors, leading to significant disability. This study highlights the importance of implementing culturally sensitive, interdisciplinary interventions for early diagnosis, better treatment adherence, and improved health outcomes tailored to the community's specific sociocultural context.

Elsevier,

Internet and Higher Education, Volume 66, June 2025

This article describes the design, development, and evaluation of a virtual assistant named 'Taylor' that was created to support disabled students in sharing information about their disabilities and learning about available support and adjustments at a distance-learning university.
RELX

More than 800 people from over 75 countries came together virtually on 3rd June 2025 for the eleventh edition of the RELX SDG Inspiration Day: "The Future of Philanthropy: Stepping up for the SDGs" The annual online event brings together together business, academia, NGOs and government to explore pressing issues and inspire action on the United Nations Sustainable Development Goals (SDGs). Explore highlights from the day including inspiring keynotes from Ban Ki-moon, 8th Secretary General of the United Nations, Sir Lenny Henry and Sarah, Duchess of York.

Elsevier,

SSM Population Health, 2025, 101826

This study identified seven distinct area-level deprivation trajectories in Northern Ireland from 2010 to 2016 and found that upward social mobility was generally linked to reduced risk of poor health outcomes, while downward mobility increased such risks compared to stable deprivation groups. Notably, a dose-response relationship emerged between lower deprivation at the endpoint and better health outcomes, though one upwardly mobile group exhibited unexpectedly high health risks, underscoring the complexity of social mobility's impact on health.

Elsevier,

International Journal of Hygiene and Environmental Health, 2025, 114614

The article reports widespread exposure to the endocrine-disrupting chemical di-n-hexyl phthalate (DnHxP) in Danish pregnant women, children, and adults, with significantly higher exposures during the summer months, likely due to contamination of the UV-filter diethylamino hydroxybenzyl hexyl benzoate (DHHB) in sunscreen products

Elsevier,

Journal of Endometriosis and Uterine Disorders, 2025, 100124

This study examined racial/ethnic disparities in the surgical management of endometriosis using data from the National Survey of Family Growth (NSFG) 2017-2019 cycle.�

Elsevier,

Pharmacological Research, Volume 216, June 2025

The article discusses the potential of glucagon-like peptide-1 (GLP-1) receptor agonists (GRA) as novel therapeutic agents for neurodegenerative diseases (NDs) like Alzheimer's disease (AD) and Parkinson's disease (PD). GRA have shown promising effects in modulating neuroinflammation, oxidative stress, mitochondrial and autophagic functions, and protein misfolding in preclinical studies. Clinical trials have demonstrated that GRA like exenatide, liraglutide, and lixisenatide can improve motor deficits in PD and cognitive function in AD patients.
Elsevier,

Journal of Prevention of Alzheimer's Disease, Volume 12, 1 June 2025

This article provides a narrative review of the relationships between modifiable lifestyle factors and plasma biomarkers of Alzheimer's disease (AD). The key findings are that better nutrition, more physical activity, and good sleep quality are associated with more favorable plasma AD biomarker profiles, potentially reflecting less cerebral AD pathology.
Elsevier,

Journal of Vascular Surgery, Volume 81, June 2025

This study indicates neurofibrillary tangles(NFT) level detection in patients with extracranial carotid atherosclerotic disease (ECAD) could enable earlier identification of those at high risk for developing Alzheimer's and other dementias, sometimes decades before symptoms. As blood-based assays to quantify NFT's are more clinically available, this could guide more targeted prevention and early treatment strategies for patients.

Pages